Hirokazu Miki

2.5k total citations
81 papers, 1.6k citations indexed

About

Hirokazu Miki is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Hirokazu Miki has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 28 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in Hirokazu Miki's work include Multiple Myeloma Research and Treatments (29 papers), Peptidase Inhibition and Analysis (9 papers) and Cancer Mechanisms and Therapy (6 papers). Hirokazu Miki is often cited by papers focused on Multiple Myeloma Research and Treatments (29 papers), Peptidase Inhibition and Analysis (9 papers) and Cancer Mechanisms and Therapy (6 papers). Hirokazu Miki collaborates with scholars based in Japan, United States and Mongolia. Hirokazu Miki's co-authors include Masahiro Abe, Shuji Ozaki, Toshio Matsumoto, Koichiro Hayashi, Michihiro Nakamura, Kazunori Ishimura, Wataru Sakamoto, Toshinobu Yogo, Shingen Nakamura and Kumiko Kagawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Hirokazu Miki

74 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirokazu Miki Japan 21 508 501 368 327 299 81 1.6k
Peipei Xu China 24 800 1.6× 576 1.1× 372 1.0× 339 1.0× 205 0.7× 159 2.2k
Marta Truffi Italy 24 704 1.4× 394 0.8× 405 1.1× 379 1.2× 210 0.7× 69 1.7k
David M. Weinreich United States 20 685 1.3× 427 0.9× 374 1.0× 453 1.4× 115 0.4× 32 2.8k
Dengfeng Cheng China 24 740 1.5× 576 1.1× 410 1.1× 287 0.9× 95 0.3× 125 2.1k
Lei Yu China 32 1.1k 2.2× 663 1.3× 495 1.3× 982 3.0× 148 0.5× 104 2.7k
Alexandre Detappe United States 22 887 1.7× 552 1.1× 357 1.0× 540 1.7× 232 0.8× 62 2.1k
Weiqi Lu China 26 886 1.7× 161 0.3× 293 0.8× 448 1.4× 176 0.6× 120 2.5k
Liyuan Ma China 23 703 1.4× 390 0.8× 99 0.3× 185 0.6× 239 0.8× 68 1.5k
Changhao Cui China 23 587 1.2× 319 0.6× 226 0.6× 172 0.5× 101 0.3× 50 1.6k

Countries citing papers authored by Hirokazu Miki

Since Specialization
Citations

This map shows the geographic impact of Hirokazu Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Miki more than expected).

Fields of papers citing papers by Hirokazu Miki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokazu Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Miki. The network helps show where Hirokazu Miki may publish in the future.

Co-authorship network of co-authors of Hirokazu Miki

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Miki. A scholar is included among the top collaborators of Hirokazu Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Miki. Hirokazu Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Yuki, Toshiki Otoda, Tomoyuki Yuasa, et al.. (2025). Red blood cell distribution width is associated with renal tubular injury in individuals with type 2 diabetes. Journal of Diabetes Investigation. 16(12). 2191–2200.
2.
Iida, Shinsuke, Shigeki Ito, Kazutaka Sunami, et al.. (2025). JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM). International Journal of Hematology. 122(4). 465–509.
3.
Inoue, Yusuke, Asuka Oda, Kimiko Sogabe, et al.. (2024). Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid. International Journal of Hematology. 119(6). 626–630. 1 indexed citations
4.
Takao, Shoichiro, Michiko Yamashita, Kimiko Sogabe, et al.. (2024). Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study. BMJ Supportive & Palliative Care. 15(5). 672–676.
5.
Yanagiya, Shin‐ichiro, Takeshi Honda, Hiroki Takanari, et al.. (2024). Raman microspectroscopy for label‐free diagnosis of amyloid light‐chain amyloidosis in various organs. Journal of Raman Spectroscopy. 55(7). 753–760. 2 indexed citations
6.
Harada, Takeshi, et al.. (2024). Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis. The Journal of Medical Investigation. 71(3.4). 335–339.
7.
Inoue, Yusuke, Jumpei Teramachi, Asuka Oda, et al.. (2024). Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction. Cancer Science. 116(2). 559–563. 1 indexed citations
8.
Yamada, Hiroki, Naoto Okada, Shingen Nakamura, et al.. (2022). A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy. The Pharmacogenomics Journal. 22(4). 241–246. 1 indexed citations
9.
Harada, Takeshi, Hiroto Ohguchi, Asuka Oda, et al.. (2022). Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase. Blood Advances. 7(6). 1019–1032. 2 indexed citations
10.
Kagawa, Kumiko, Takashi Saito, Kimiko Sogabe, et al.. (2021). Allogeneic haematopoietic stem cell transplantation—clinical outcomes: impact of leg muscle strength. BMJ Supportive & Palliative Care. 16(1). 180–187. 6 indexed citations
11.
Hirata, Yukina, Kenya Kusunose, Hirokazu Miki, & Hirotsugu Yamada. (2019). Improvement of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with amyloid light-chain cardiac amyloidosis: a case report. European Heart Journal - Case Reports. 3(4). 1–6. 4 indexed citations
12.
Nakamura, Shingen, Momoyo Azuma, Kimiko Sogabe, et al.. (2018). Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome. Journal of Infection and Chemotherapy. 24(5). 389–392. 32 indexed citations
13.
Miki, Hirokazu, Takeshi Harada, Qu Cui, et al.. (2016). Expansion of γδT Cells By New Generation IMiDs and Their Cytotoxicity Against Myeloma Progenitors. Blood. 128(22). 2107–2107. 1 indexed citations
14.
Nakatake, Richi, Masaki Kaibori, Hirokazu Miki, et al.. (2015). Glutamic Acid Has a Liver-Protective Effect through the Suppression of Inducible Nitric Oxide Synthase in Primary Cultured Rat Hepatocytes. International journal of advanced research in chemical sciences. 2(10). 47–63. 2 indexed citations
15.
Abe, Masahiro, Hirokazu Miki, & Shingen Nakamura. (2015). [Management of bone disease in myeloma patients: zoledronic acid or denosumab?].. PubMed. 56(8). 997–1004. 1 indexed citations
16.
Harada, Takeshi, Shuji Ozaki, Asuka Oda, et al.. (2013). Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma. International Journal of Hematology. 97(6). 743–748. 20 indexed citations
17.
Harada, Takeshi, Shuji Ozaki, Asuka Oda, et al.. (2013). Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors. PLoS ONE. 8(12). e83905–e83905. 13 indexed citations
18.
Inoue, Kentaro, Yasushi Nakane, Taku Michiura, et al.. (2012). Ultrasonic Scalpel for Gastric Cancer Surgery: a Prospective Randomized Study. Journal of Gastrointestinal Surgery. 16(10). 1840–1846. 25 indexed citations
19.
Nakano, Ayako, Masahiro Abe, Daisuke Tsuji, et al.. (2011). Inhibition of Hexokinase II Inactivates ABC Transporters and Restores Drug Sensitivity in Myeloma Cells. Blood. 118(21). 135–135. 1 indexed citations
20.
Takeuchi, Kyoko, Masahiro Abe, Masahiro Hiasa, et al.. (2010). TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth. PLoS ONE. 5(3). e9870–e9870. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peipei Xu Breakdown of academic impact, for papers by Marta Truffi Breakdown of academic impact, for papers by David M. Weinreich Breakdown of academic impact, for papers by Dengfeng Cheng Breakdown of academic impact, for papers by Lei Yu Breakdown of academic impact, for papers by Alexandre Detappe Breakdown of academic impact, for papers by Weiqi Lu Breakdown of academic impact, for papers by Liyuan Ma Breakdown of academic impact, for papers by Changhao Cui
Rankless by CCL
2026